Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1992 1
1993 1
1994 1
1999 1
2002 2
2003 1
2004 3
2005 3
2006 3
2007 5
2008 3
2009 3
2010 8
2011 7
2012 15
2013 7
2014 8
2015 7
2016 7
2017 14
2018 17
2019 22
2020 16
2021 15
2022 25
2023 37
2024 15
2025 36
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

248 results

Results by year

Filters applied: . Clear all
Page 1
The Roles of Serotonin in Neuropsychiatric Disorders.
Pourhamzeh M, Moravej FG, Arabi M, Shahriari E, Mehrabi S, Ward R, Ahadi R, Joghataei MT. Pourhamzeh M, et al. Cell Mol Neurobiol. 2022 Aug;42(6):1671-1692. doi: 10.1007/s10571-021-01064-9. Epub 2021 Mar 2. Cell Mol Neurobiol. 2022. PMID: 33651238 Free PMC article. Review.
Moreover, we provided experimental and clinical evidence of 5-HT's involvement in neuropsychiatric disorders and discussed the molecular mechanisms that underlie these illnesses and contribute to the new therapies....
Moreover, we provided experimental and clinical evidence of 5-HT's involvement in neuropsychiatric disorders and discussed the molecu …
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis.
Silverberg JI, Guttman-Yassky E, Thaçi D, Irvine AD, Stein Gold L, Blauvelt A, Simpson EL, Chu CY, Liu Z, Gontijo Lima R, Pillai SG, Seneschal J; ADvocate1 and ADvocate2 Investigators. Silverberg JI, et al. N Engl J Med. 2023 Mar 23;388(12):1080-1091. doi: 10.1056/NEJMoa2206714. Epub 2023 Mar 15. N Engl J Med. 2023. PMID: 36920778 Clinical Trial.
Outcomes for the induction period were assessed up to 16 weeks and are included in this report. The primary outcome was an Investigator's Global Assessment (IGA) score of 0 or 1 (indicating clear or almost clear skin; range, 0 to 4 [severe disease]) with a reduction (indic …
Outcomes for the induction period were assessed up to 16 weeks and are included in this report. The primary outcome was an Investigator's …
Lebrikizumab Provides Rapid Clinical Responses Across All Eczema Area and Severity Index Body Regions and Clinical Signs in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis.
Simpson EL, de Bruin-Weller M, Hong HC, Staumont-Sallé D, Blauvelt A, Eyerich K, Gooderham M, Shahriari M, Mallbris L, Atwater AR, Rueda MJ, Ding Y, Liu Z, Agell H, Silverberg JI. Simpson EL, et al. Dermatol Ther (Heidelb). 2024 May;14(5):1145-1160. doi: 10.1007/s13555-024-01158-4. Epub 2024 May 3. Dermatol Ther (Heidelb). 2024. PMID: 38700646 Free PMC article.
Redox reactions in vitrified-warmed ovary.
Rahimi A, Shahriari A, Barati F. Rahimi A, et al. F S Sci. 2024 Feb;5(1):39-42. doi: 10.1016/j.xfss.2023.11.002. Epub 2023 Nov 10. F S Sci. 2024. PMID: 37952929
Public access defibrillation: challenges and new solutions.
Folke F, Shahriari P, Hansen CM, Gregers MCT. Folke F, et al. Curr Opin Crit Care. 2023 Jun 1;29(3):168-174. doi: 10.1097/MCC.0000000000001051. Epub 2023 Apr 24. Curr Opin Crit Care. 2023. PMID: 37093002 Free PMC article. Review.
The actin-binding protein palladin associates with the respiratory syncytial virus matrix protein.
Shahriari S, Ghildyal R. Shahriari S, et al. J Virol. 2024 Oct 22;98(10):e0143524. doi: 10.1128/jvi.01435-24. Epub 2024 Oct 3. J Virol. 2024. PMID: 39360826 Free PMC article.
The M-actin interaction may play a role in facilitating the transportation of virion components to the apical surface, where RSV is released. We show that M protein's association with actin is facilitated by palladin, an actin-binding protein. Cells were infected with RSV …
The M-actin interaction may play a role in facilitating the transportation of virion components to the apical surface, where RSV is released …
Tralokinumab as a Therapeutic Alternative for Dupilumab-associated Arthralgia in Atopic Dermatitis: A Multi-center Case Series.
Greenberg ABW, Shahriari M, Cameron MC, Payette M, Dasilva DR, Damiani G, Herman EI, Eminger LA, Issa NT, Rodriguez A, Del Rosso JQ, Kang Y, Cohen JM, Bunick CG. Greenberg ABW, et al. J Clin Aesthet Dermatol. 2025 May 1;18(5):16-19. J Clin Aesthet Dermatol. 2025. PMID: 40538523 Free PMC article.
All 15 patients achieved clear or nearly clear skin and demonstrated reductions in AD signs and symptoms as measured by Investigator's Global Assessment (IGA), body surface area of involvement (BSA), and/or patient reported measures of pruritus. ...
All 15 patients achieved clear or nearly clear skin and demonstrated reductions in AD signs and symptoms as measured by Investigator's …
Guselkumab for Moderate to Severe Psoriasis Across All Skin Tones: Cohort A of the VISIBLE Randomized Clinical Trial.
Alexis A, McMichael A, Soung J, Choi O, Alkousakis T, Alonso-Llamazares J, Shahriari M, Rodriguez AO, Bhutani T, Chan D, Rowland K, Sauder M, Hong HC, Yadav G, Yeung J, Jeyarajah J, Ma T, Gao LL, Park-Wyllie L, Green L, Lee M, Vashi N, Kindred C, Grimes P, Taylor SC, Desai SR; VISIBLE Trial Investigators. Alexis A, et al. JAMA Dermatol. 2025 Sep 1;161(9):901-911. doi: 10.1001/jamadermatol.2025.1836. JAMA Dermatol. 2025. PMID: 40560559 Free PMC article. Clinical Trial.
DESIGN, SETTING, AND PARTICIPANTS: This ongoing phase 3b, randomized clinical trial at 39 sites in the US and Canada enrolled adults with skin of color and moderate to severe psoriasis (body surface area [BSA] 10%; Psoriasis Area and Severity Index [PASI] 12; Investigator's …
DESIGN, SETTING, AND PARTICIPANTS: This ongoing phase 3b, randomized clinical trial at 39 sites in the US and Canada enrolled adults with sk …
Guselkumab for Moderate to Severe Scalp Psoriasis Across All Skin Tones: Cohort B of the VISIBLE Randomized Clinical Trial.
McMichael A, Shahriari M, Stein Gold L, Alkousakis T, Choi O, Bhutani T, Rodriguez AO, Tyring SK, Chan D, Rowland K, Albrecht L, Lynde C, Yadav G, Yeung J, Park-Wyllie L, Ma T, Jeyarajah J, Gao LL, Smith S, Moore AY, Vashi N, Kindred C, Grimes P, Desai SR, Taylor SC, Alexis A; VISIBLE Trial Investigators. McMichael A, et al. JAMA Dermatol. 2025 Sep 1;161(9):912-922. doi: 10.1001/jamadermatol.2025.1849. JAMA Dermatol. 2025. PMID: 40560554 Free PMC article. Clinical Trial.
DESIGN, SETTING, AND PARTICIPANTS: This ongoing phase 3b, randomized clinical trial at 45 sites in the US and Canada enrolled adults with skin of color and moderate to severe scalp psoriasis (scalp surface area [SSA] 30%; Psoriasis Scalp Severity Index [PSSI] 12; scalp-specific …
DESIGN, SETTING, AND PARTICIPANTS: This ongoing phase 3b, randomized clinical trial at 45 sites in the US and Canada enrolled adults with sk …
Clergy's Viewpoint Change Toward Mental Health and Stigma on Mental Illness: A Short Course Training.
Taghva A, Noorbala AA, Khademi M, Shahriari A, Nasr Esfahani M, Asadi A, Mohsenifar J, Yousefifard A, Abolhassani M, Bolhari J, Hajebi A, Rahnejat AM, Shahed-Haghghadam H. Taghva A, et al. Front Psychiatry. 2022 Apr 1;13:864806. doi: 10.3389/fpsyt.2022.864806. eCollection 2022. Front Psychiatry. 2022. PMID: 35432029 Free PMC article.
BACKGROUND: As stigma is one of the main barriers in promoting the mental health, the present study was designed with the purpose of reviewing clergy's viewpoint regarding the effect of mental health workshops on these barriers. METHODS: For this study, by order of Iran' …
BACKGROUND: As stigma is one of the main barriers in promoting the mental health, the present study was designed with the purpose of reviewi …
248 results